Fast modulation of heat-activated ionic current by proinflammatory interleukin 6 in rat sensory neurons

Brain. 2005 Jul;128(Pt 7):1634-41. doi: 10.1093/brain/awh490. Epub 2005 Apr 7.

Abstract

The pro-inflammatory cytokine interleukin-6 (IL-6) together with its soluble receptor (sIL-6R) induces and maintains thermal hyperalgesia. It facilitates the heat-induced release of calcitonin gene-related peptide from rat cutaneous nociceptors in vivo and in vitro. Here we report that exposure of nociceptive neurons to the IL-6-sIL-6R complex or the gp130-stimulating designer IL-6-sIL-6R fusion protein Hyper-IL-6 (HIL-6) resulted in a potentiation of heat-activated inward currents (I(heat)) and a shift of activation thresholds towards lower temperatures without affecting intracellular calcium levels. The Janus tyrosine kinase inhibitor AG490, the selective protein kinase C (PKC) inhibitor, bisindolylmaleimide 1 (BIM1), as well as rottlerin, a selective blocker of the PKCdelta isoform, but not the cyclooxygenase inhibitor indomethacin, effectively reduced the effect. Reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization revealed expression of mRNA for the signal-transducing beta subunit of the receptor gp130 in neuronal somata, rather than satellite cells in rat dorsal root ganglia. Together, the results suggest that IL-6-sIL-6R acts directly on sensory neurons. It increases their susceptibility to noxious heat via the gp130/Jak/PKCdelta signalling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetophenones / pharmacology
  • Animals
  • Antigens, CD / genetics
  • Antigens, CD / metabolism
  • Benzopyrans / pharmacology
  • Calcium / metabolism
  • Cells, Cultured
  • Cyclooxygenase Inhibitors / pharmacology
  • Cytokine Receptor gp130
  • Female
  • Ganglia, Spinal / drug effects
  • Ganglia, Spinal / physiology*
  • Hot Temperature / adverse effects*
  • In Situ Hybridization
  • Indoles / pharmacology
  • Indomethacin / pharmacology
  • Interleukin-6 / genetics
  • Interleukin-6 / pharmacology*
  • Janus Kinase 1
  • Maleimides / pharmacology
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism
  • Neurons, Afferent / drug effects
  • Neurons, Afferent / physiology*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C-delta
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • RNA, Messenger / analysis
  • Rats
  • Rats, Wistar
  • Receptors, Interleukin-6 / genetics
  • Receptors, Interleukin-6 / metabolism*
  • Recombinant Fusion Proteins / pharmacology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sensory Thresholds / drug effects
  • Signal Transduction / drug effects
  • Tyrphostins / pharmacology

Substances

  • Acetophenones
  • Antigens, CD
  • Benzopyrans
  • Cyclooxygenase Inhibitors
  • Il6st protein, rat
  • Indoles
  • Interleukin-6
  • Maleimides
  • Membrane Glycoproteins
  • RNA, Messenger
  • Receptors, Interleukin-6
  • Recombinant Fusion Proteins
  • Tyrphostins
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • Cytokine Receptor gp130
  • rottlerin
  • Prkcd protein, rat
  • Protein-Tyrosine Kinases
  • Jak1 protein, rat
  • Janus Kinase 1
  • Protein Kinase C
  • Protein Kinase C-delta
  • bisindolylmaleimide
  • Calcium
  • Indomethacin